Higher vigilance needed to diagnose and treat MDD
Loading...
Date
Authors
Du Plessis, Ilse
Journal Title
Journal ISSN
Volume Title
Publisher
New Media Publishing
Abstract
Selective serotonin reuptake inhibitors (SSRIs) became the first line of treatment of depressive disorders (MDD) during the eighties and has kept its place in the arsenal of options to treat this common disease. MDD accounts for 4,4% of the total overall global disease burden.
Description
Keywords
Treatment, Disease, Major depressive disorder (MDD), Selective serotonin reuptake inhibitors (SSRIs)
Sustainable Development Goals
Citation
Du Plessis, I 2015, 'Higher vigilance needed to diagnose and treat MDDs', Specialist Forum, vol. 15, no. 7, pp. 12.